Shuttle Pharmaceuticals Holdings, Inc. SHPH
4.01
0.01
0.25%
as of 25 Sep
- Market cap
- $15.6M
- P/E
- 34.7×
Follow SHPH
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
Current Ratio |
0.06 | 1.44 | 5.37 | 8.79 | 0.23 | 0.16 | 1.03 | 0.25 |
Net Debt/EBITDA |
0.03 | 0.29 | 1.42 | 4.29 | 0.26 | (1.54) | (0.08) | (1.42) |
Debt/Assets |
0.00% | 0.00% | 2.27% | 0.00% | 9.58% | 149.96% | 64.38% | 259.19% |
Debt/Equity |
0.00 | 0.00 | 0.03 | 0.00 | (0.04) | (0.48) | 14.55 | (1.11) |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.81 | 0.80 | 0.85 | 0.40 | 0.24 | 0.03 | 0.91 | 0.95 |
Capex/Depreciation |
(8.68) | 0.00 | (0.01) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (791.04%) | (383.83%) | (112.37%) | (223.05%) | 75.65% | 109.31% | 487.62% | 0.00% | |
| (180.58%) | (216.24%) | (90.28%) | (145.02%) | (209.97%) | (155.98%) | (168.62%) | 0.00% | |
ROIC |
(387.84%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
157.41% | (1,312.96%) | (144.08%) | (88.60%) | 74.31% | 57.98% | (2,981.43%) | 75.13% |
Average Days of Receivables |
— | — | — | — | — | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.94 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | — | — |
Free Cash Flow per Share |
(76.55) | (637.15) | (746.68) | (493.78) | (63.89) | 0.00 | (0.04) | (0.01) |
Cash per Share |
2.04 | 166.97 | 728.48 | 1,558.74 | 107.38 | 0.01 | 0.03 | 0.00 |
Shareholders Equity per Share |
13.76 | 61.67 | 540.77 | 1,421.83 | (346.40) | (0.12) | 0.00 | (0.02) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
13.76 | 61.67 | 540.77 | 1,421.83 | (346.40) | (0.12) | 0.00 | (0.02) |
Free Cash Flow |
(12.54) | (7.33) | (5.60) | (2.67) | (0.30) | (0.03) | (0.57) | (0.20) |
Working Capital |
(7.46) | 0.68 | 4.55 | 7.60 | (1.71) | (1.76) | 0.02 | (0.30) |
Capital Expenditures |
(3.06) | — | (0.02) | — | — | (0.01) | — | — |
Net Current Asset Value |
(7.72) | 0.41 | 3.70 | 7.60 | (1.77) | (1.89) | 0.02 | (0.30) |
| Other line items | ||||||||
Quick Ratio |
0.04 | 1.25 | 5.24 | 8.63 | 0.23 | 0.16 | 0.60 | 0.25 |
Depreciation/Fixed assets |
20.35 | 55.92 | 85.88 | 30.43 | 3.45 | 0.28 | 22.50 | 0.99 |
Cash ROIC |
(366.98%) | (279.41%) | (58.07%) | (16.64%) | 30.06% | 29.47% | (72.77%) | (274.13%) |
Accounts Receivable Turnover |
— | — | — | — | — | 0.00 | 0.00 | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.33 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 622.53 | 1,543.93 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(57.89) | (637.15) | (744.15) | (493.78) | (63.89) | 0.00 | (0.04) | (0.01) |
Capex per Share |
(18.66) | 0.00 | (2.53) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | — | — | — | 0.11 | 0.03 | — |
Average Payables |
1.03 | 0.44 | 0.21 | 0.48 | 0.43 | — | 0.05 | — |
Average Assets |
6.49 | 4.23 | 7.30 | 4.65 | 0.60 | 0.58 | 0.37 | — |
Average Common Equity |
1.48 | 2.38 | 5.87 | 3.02 | (1.66) | (0.83) | (0.13) | — |
Capex to Sales |
0.00 | — | 0.00 | — | — | — | — | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates